Group IMW. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749–57.

Article  Google Scholar 

Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–48.

Article  PubMed  Google Scholar 

Caers J, Paiva B, Zamagni E, Leleu X, Blade J, Kristinsson SY, et al. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel. J Hematol Oncol. 2018;11:10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, et al. Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the international lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys. 2018;101:794–808.

Article  PubMed  Google Scholar 

Zhang Y, Qi J, Qiu L. Multiple solitary plasmacytoma: characteristics, response to therapy, survival in nine patients from a single institute. Blood. 2013;122:5383.

Article  Google Scholar 

Yang B, Wang J, Cai LL, Zhu HL, Yu RL, Chi XH, et al. Treatment of multiple solitary plasmacytomas with cytokine-induced killer cells. Cytotherapy. 2014;16:278–84.

Article  CAS  PubMed  Google Scholar 

Cafferata MA, Chiaramondia M, Monetti F, Ardizzoni A. Complete spontaneous remission of non-small-cell lung cancer: a case report. Lung Cancer. 2004;45:263–6.

Article  CAS  PubMed  Google Scholar 

Wiernik PH. Spontaneous regression of hematologic cancers. Natl Cancer Inst Monogr. 1976;44:35–8.

CAS  PubMed  Google Scholar 

Gattiker HH, Wiltshaw E, Galton DA. Spontaneous regression in non-Hodgkin’s lymphoma clinical and pathogenetic considerations. Cancer. 1980;45:2627–32.

Article  CAS  PubMed  Google Scholar 

Drobyski WR, Qazi R. Spontaneous regression in non-Hodgkin’s lymphoma clinical and pathogenetic considerations. Am J Hematol. 1989;31:138–41.

Article  CAS  PubMed  Google Scholar 

Papac R. Spontaneous regression of cancer. Cancer Treat Rev. 1996;22:395–423.

Article  CAS  PubMed  Google Scholar 

Arunabh, Dutta Gupta S, Bal S, Sarda A, Vijayraghavan M, Shukla N, et al. Spontaneous regression of extramedullary plasmacytoma -a case report. Jpn J Surg. 1988;18:455–9.

Article  CAS  PubMed  Google Scholar 

Meziane M, Boulaadas M, Essakalli L, Kzadri M, Harmouch A. Solitary plasmocytoma: ghost tumour? Int J Oral Maxillofac Surg. 2012;41:17–9.

Article  CAS  PubMed  Google Scholar 

Oken M, Creech R, Tormey D, Horton J, Davis T, McFadden E, et al. Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Onco. 1982;5:649–55.

Article  CAS  Google Scholar 

Abe R, Ogawa K, Maruyama Y, Nakamura N, Abe M. Spontaneous regression of diffuse large b-cell lymphoma harbouring epstein-barr virus a case report and review of the literature. J Clin Exp Hematop. 2007;47:23–6.

Article  PubMed  Google Scholar 

Tanaka Y, Ishihara M, Miyoshi H, Hashimoto A, Shinzato I, Ohshima K. Spontaneous regression of diffuse large B-cell lymphoma in the small intestine with multiple lymphadenopathy. J Clin Exp Hematop. 2019;59:17–21.

Article  PubMed  PubMed Central  Google Scholar 

Krikorian JG, Portlock CS, Cooney P. Spontaneous regression of non-Hodgkin’s lymphoma a report of nine case. Cancer. 1980;46:2093–9.

Article  CAS  PubMed  Google Scholar 

Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Engl J Med. 1984;11:1471–5.

Article  Google Scholar 

Puig N, Trudel S, Keats JJ, Li ZH, Braggio E, Ahmann GJ, et al. Spontaneous remission in a patient with t(4;14) translocation multiple myeloma. J Clin Oncol. 2009;27:e194–7.

Article  PubMed  Google Scholar 

Tambo A, Marukawa K, Watanabe A, Nozaki S. Spontaneous remission of mandibular plasmablastic plasma cell myeloma with numb chin syndrome: a case report. J Oral Maxillofac Surg Med Pathol. 2023. https://doi.org/10.1016/j.ajoms.2023.07.004.

Article  Google Scholar 

Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, et al. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013;91:20–8.

Article  CAS  PubMed  Google Scholar 

Gion Y, Iwaki N, Takata K, Takeuchi M, Nishida K, Orita Y, et al. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci. 2017;108:1271–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurita D, Miyoshi H, Ichikawa A, Kato K, Imaizumi Y, Seki R, et al. Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis clinicopathologic features and prognostic factors. Am J Surg Pathol. 2019;43:869–84.

Article  PubMed  Google Scholar 

Kim SH, Kim TH, Sohn JW, Yoon HJ, Shin DH, Kim IS, et al. Primary pulmonary plasmacytoma presenting as multiple lung nodules. Korean J Intern Med. 2012;27:111–3.

Article  PubMed  PubMed Central  Google Scholar 

Sekiguchi Y, Shimada A, Ichikawa K, Wakabayashi M, Sugimoto K, Ikeda K, et al. Epstein-Barr virus-positive multiple myeloma developing after immunosuppressant therapy for rheumatoid arthritis a case report and review of literature. Int J Clin Exp. 2015;8:2090–102.

Google Scholar 

Tokunaga T, Hashimoto H, Yoshida Y, Sugimoto T, Mokuda S, Kosaka Y, et al. Immunoglobulin D-kappa multiple myeloma in a patient with rheumatoid arthritis: a case report and review of the literature. Mod Rheumatol Case Rep. 2021;5:22–8.

Article  PubMed  Google Scholar 

Zhou T, Cheng J, Karrs J, Davies-Hill T, Pack SD, Xi L, et al. Clinicopathologic and molecular characterization of epstein-barr virus-positive plasmacytoma. Am J Surg Pathol. 2022;46:1364–79.

Article  PubMed  Google Scholar 

Ohgaki F, Takemoto Y, Paku S, Tatezuki J, Kumagai J, Shuto T, et al. Primary central nervous system other iatrogenic immunodeficiency-associated lymphoproliferative disorders presenting as extraosseous plasmacytoma with a progressive clinical course: a case report and literature review. Neuropathology. 2023;43:151–7.

Article  PubMed  Google Scholar 

Saito S, Kaneko Y, Yamaoka K, Tokuhira M, Takeuchi T. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate. Rheumatology. 2017;56:940–6.

Article  CAS  PubMed  Google Scholar 

Berti A, Felicetti M, Peccatori S, Bortolotti R, Guella A, Vivaldi P, et al. EBV-induced lymphoproliferative disorders in rheumatic patients A systematic review of the literature. Joint Bone Spine. 2018;85:35–40.

Article  PubMed  Google Scholar 

Tokuhira M, Tanaka Y, Takahashi Y, Kimura Y, Tomikawa T, Anan T, et al. The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders. J Clin Exp Hematop. 2020;60:41–50.

Article  PubMed  PubMed Central  Google Scholar 

Saito S, Suzuki K, Yoshimoto K, Kaneko Y, Yamaoka K, Shimizu T, et al. Restoration of decreased T Helper 1 and CD8+ T cell subsets is associated with regression of lymphoproliferative disorders developed during methotrexate treatment. Front Immunol. 2018;9:621.

Article  PubMed  PubMed Central  Google Scholar 

Hoeller S, Tzankov A, Pileri SA, Went P, Dirnhofer S. Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations. Hum Pathol. 2010;41:352–7.

Article  PubMed  Google Scholar 

Hong JY, Yoon DH, Suh C, Huh J, Do IG, Sohn I, et al. EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity? Ann Oncol. 2015;26:548–55.

Article  CAS  PubMed  Google Scholar 

Tashiro H, Brenner MK. Immunotherapy against cancer-related viruses. Cell Res. 2017;27:59–73.

Article  CAS  PubMed  Google Scholar 

Tokuhira M, Kimura Y, Takahashi Y, Tomikawa T, Sagawa M, Anan T, et al. Impact Of Epstein-Barr viral infection in the regression of methotrexate-induced lymphoproliferative diseases in patients with rheumatoid arthritis. Blood. 2013;122:3006.

Article  Google Scholar 

Rosenblatt J, Avigan D. Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality? Blood. 2017;129:275–9.

Article  CAS  PubMed  Google Scholar 

Ishibashi M, Tamura H, Sunakawa M, Kondo-Onodera A, Okuyama N, Hamada Y, et al. Myeloma drug resistance induced by binding of myeloma B7–H1 (PD-L1) to PD-1. Cancer Immunol Res. 2016;4:779–88.

Article  CAS  PubMed  Google Scholar 

Lee BH, Park Y, Kim JH, Kang KW, Lee SJ, Kim SJ, et al. PD-L1 expression in bone marrow plasma cells as a biomarker to predict m